Discover key insights from Profound Medical's Q2 2025 earnings call, highlighting 70%-75% expected revenue growth, TULSA-AI launch, and CAPTAIN trial success.

Profound Medical ( ($TSE:PRN) ) just unveiled an update. Profound Medical reported its second quarter 2025 financial results, highlighting a 10% ...

As AI chatbots like ChatGPT and Perplexity reshape how people search—siphoning queries away from Google—startups are racing to help brands stay visible in AI-generated responses. Profound, which ...

Profound Medical (PROF) reviews Q2 2025 results, focusing on TULSA-PRO pipeline growth, AI-powered BPH solutions & trials driving adoption.

Thanks to Profound, Airbyte tripled its visibility in ChatGPT-from 9% to 26% in a week-and converted that visibility into a ...